EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of leukocyte count with atherosclerotic cardiovascular disease in patients with genetically defined familial hypercholesterolaemia

Seyed Saeed Tamehri Zadeh, Dick C Chan, Jing Pang, Gerald F Watts

Nutrition, Metabolism and Cardiovascular Diseases · 2026

DOI: 10.1016/j.numecd.2025.104457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026. Verfasst von Seyed Saeed Tamehri Zadeh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, University of Western Australia, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II, Atherosclerosis, Neutrophils, Monocytes. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Familial hypercholesterolaemia (FH) is characterized by elevated low-density lipoprotein-cholesterol and increased risk of atherosclerotic cardiovascular disease (ASCVD). Systemic inflammation has been recognized as a contributor to ASCVD. However, its role in patients with heterozygous FH (HeFH) remains unclear. This study examined the association between systemic inflammatory markers and ASCVD risk in HeFH patients. METHODS AND RESULTS: A cross-sectional study of 538 patients with genetically confirmed HeFH were studied. Logistic regression was employed to assess the association between white blood cell count (WBCC), neutrophil count (NC) and monocyte count (MC) and prevalent ASCVD. HeFH patients with ASCVD had higher levels of WBCC, NC and MC than those without ASCVD. A 1-standard deviation increase in WBCC (odds ratio 1.65 [95 % CI: 1.29-2.12]), NC (1.64 [1.29-2.10]) and MC (1.56 [1.21-2.02]) were independently associated with higher ASCVD risk. The upper and middle tertiles of WBCC, NC and MC had a two- to three-fold increased risk of ASCVD compared with those in the bottom tertile. CONCLUSIONS: Higher levels of WBCC, NC and MC are significantly associated with an increased prevalence of ASCVD in patients with HeFH. Targeting inflammation may be a valuable strategy for managing the development and progression of ASCVD in FH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperlipoproteinemia Type IIAtherosclerosisNeutrophilsMonocytesHumansMaleFemaleCross-Sectional StudiesMiddle AgedLeukocyte CountAdultRisk AssessmentPrevalenceBiomarkersInflammation MediatorsPhenotypeGenetic Predisposition to DiseaseRisk FactorsInflammationHeterozygotePredictive Value of TestsAgedPrognosis

Stichwörter der Autor:innen

Cardiovascular diseaseFamilial hypercholesterolaemiaWhite blood cells

Substanzen

BiomarkersInflammation Mediators

Autor:innen und Institutionen

  • Medical School, University of Western Australia, Perth, Western Australia, Australia.
  • Medical School, University of Western Australia, Perth, Western Australia, Australia; Departments of Cardiology and Internal Medicine, Royal Perth Hospital, Perth, Western Australia, Australia. Electronic address: geral…

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Tamehri Zadeh, S. S., Chan, D. C., Pang, J., & Watts, G. F. (2026). Association of leukocyte count with atherosclerotic cardiovascular disease in patients with genetically defined familial hypercholesterolaemia. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2025.104457

Vancouver

Tamehri Zadeh SS, Chan DC, Pang J, Watts GF. Association of leukocyte count with atherosclerotic cardiovascular disease in patients with genetically defined familial hypercholesterolaemia. Nutrition, Metabolism and Cardiovascular Diseases. 2026. doi:10.1016/j.numecd.2025.104457

BibTeX
@article{TamehriZadeh2026,
  author = {Tamehri Zadeh, Seyed Saeed and Chan, Dick C and Pang, Jing and Watts, Gerald F},
  title = {Association of leukocyte count with atherosclerotic cardiovascular disease in patients with genetically defined familial hypercholesterolaemia},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2026},
  doi = {10.1016/j.numecd.2025.104457}
}
Kostenlos starten →